- Home
- LEGT vs KYTX Comparison
LEGT vs KYTX Comparison
Compare LEGT & KYTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEGT
- KYTX
- Stock Information
- Founded
- LEGT 2023
- KYTX 2018
- Country
- LEGT United States
- KYTX United States
- Employees
- LEGT N/A
- KYTX N/A
- Industry
- LEGT
- KYTX
- Sector
- LEGT
- KYTX
- Exchange
- LEGT Nasdaq
- KYTX NYSE
- Market Cap
- LEGT 263.0M
- KYTX 242.1M
- IPO Year
- LEGT 2024
- KYTX 2024
- Fundamental
- Price
- LEGT $10.26
- KYTX $5.29
- Analyst Decision
- LEGT
- KYTX Buy
- Analyst Count
- LEGT 0
- KYTX 4
- Target Price
- LEGT N/A
- KYTX $23.25
- AVG Volume (30 Days)
- LEGT 62.7K
- KYTX 262.9K
- Earning Date
- LEGT 01-01-0001
- KYTX 11-15-2024
- Dividend Yield
- LEGT N/A
- KYTX N/A
- EPS Growth
- LEGT N/A
- KYTX N/A
- EPS
- LEGT N/A
- KYTX N/A
- Revenue
- LEGT N/A
- KYTX N/A
- Revenue This Year
- LEGT N/A
- KYTX N/A
- Revenue Next Year
- LEGT N/A
- KYTX N/A
- P/E Ratio
- LEGT N/A
- KYTX N/A
- Revenue Growth
- LEGT N/A
- KYTX N/A
- 52 Week Low
- LEGT $10.00
- KYTX $4.40
- 52 Week High
- LEGT $10.47
- KYTX $30.60
- Technical
- Relative Strength Index (RSI)
- LEGT N/A
- KYTX 49.62
- Support Level
- LEGT N/A
- KYTX $4.78
- Resistance Level
- LEGT N/A
- KYTX $5.61
- Average True Range (ATR)
- LEGT 0.00
- KYTX 0.36
- MACD
- LEGT 0.00
- KYTX 0.06
- Stochastic Oscillator
- LEGT 0.00
- KYTX 57.45
About LEGT Legato Merger Corp. III
Legato Merger Corp III is a blank check company.
About KYTX KYVERNA THERAPEUTICS INC
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.